Sleep apnoea is common among patients with type 2 diabetes.1 It is independently associated with insulin resistance, glucose intolerance and metabolic syndrome,2-4 and when untreated, can lead to poor overall treatment outcomes.
However, despite the number of type 2 diabetes patients with SDB, it largely goes undiagnosed.
Screen your patients for type 2 diabetes and SDB
As a result of accumulated research, the International Diabetes Federation recognises the association between type 2 diabetes and sleep apnoea, and recommends routinely screening OSA patients for type 2 diabetes, and screening type 2 diabetes patients displaying sleep apnoea symptoms for OSA.
And because patients with sleep apnoea and patients with diabetes share similar comorbidities, screening both ways is recommended: check for sleep apnoea in diabetes patients, and check for diabetes in patients with sleep apnoea.5